Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

NCT05788081 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma Stage II
Follicular Lymphoma Stage III
Follicular Lymphoma Stage IV

Interventions

DRUG: golcadomide
DRUG: Nivolumab 10 MG/ML
DRUG: Rituximab

Sponsor

Olivia Newton-John Cancer Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]